Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2022)
Corcept Therapeutics (CORT) reported Interest & Investment Income of -$1.0 million for Q1 2022, down 430.73% on a YoY basis from $308107.1 in Q1 2021, and down 4330.43% sequentially from -$23000.0 in Q3 2021.
Corcept Therapeutics (CORT) Interest & Investment Income (2010 - 2022) Analysis & Trends
Corcept Therapeutics (CORT) has 8 years of Interest & Investment Income data on file, last reported at -$1.0 million in Q1 2022.
- For the quarter ending Q1 2022, Interest & Investment Income fell 430.73% year-over-year to -$1.0 million; the trailing twelve-month figure through Mar 2022 stood at -$1.3 million (down 2016.42% YoY), and the FY2019 full-year result was $327000.0, up 6440.0% from the prior year.
- Interest & Investment Income retreated to -$1.0 million in Q1 2022, from -$23000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $545000.0 in Q2 2020 to a low of -$1.0 million in Q1 2022.
- A 5-year average of -$46200.0 and a median of -$2000.0 in 2019 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 1566.67% in 2018 and tumbled 17250.0% in 2020, its largest moves.
- Tracing CORT's Interest & Investment Income over 5 years: stood at $82000.0 in 2018, then tumbled by 175.61% to -$62000.0 in 2019, then plunged by 459.68% to -$347000.0 in 2020, then soared by 93.37% to -$23000.0 in 2021, then slumped by 4330.43% to -$1.0 million in 2022.
- Business Quant data shows CORT's Interest & Investment Income at -$1.0 million in Q1 2022, -$23000.0 in Q3 2021, and -$50000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -1.02 Mn |
| Sep 30, 2021 | -23,000.00 |
| Jun 30, 2021 | -50,000.00 |
| Mar 31, 2021 | -192,000.00 |
| Sep 30, 2020 | -347,000.00 |
| Jun 30, 2020 | 545,000.00 |
| Mar 31, 2020 | 61,000.00 |
| Dec 31, 2019 | -62,000.00 |
| Sep 30, 2019 | -2,000.00 |
| Jun 30, 2019 | 227,000.00 |
| Mar 31, 2019 | 164,000.00 |
| Dec 31, 2018 | 82,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Jun 30, 2018 | 25,000.00 |
| Mar 31, 2018 | -152,000.00 |
| Dec 31, 2017 | -61,000.00 |
| Sep 30, 2017 | 3,000.00 |
| Jun 30, 2017 | -5,000.00 |
| Mar 31, 2017 | -12,000.00 |
| Sep 30, 2011 | 3,000.00 |